Breitenbach; Jorg

Patent Applications and Registrations

Patent applications and USPTO patent grants for Breitenbach; Jorg.The latest application filed is for "formulation obtained from a powder mixture comprising an inorganic pigment".

Company Profile

0.54.44

Breitenbach; Jorg - Mannheim DE
Breitenbach; Jorg - 68199 Mannheim DE
Breitenbach; Jorg - Mnnheim DE
Breitenbach; Jorg - Linz DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Production of dosage forms comprising a solid dispersion of a microcrystalline agent Grant 10,653,625 - Rosenberg , et al.	2020-05-19
Formulation Obtained from a Powder Mixture Comprising an Inorganic Pigment App 20180185287 - Fastnacht; Katja ; et al.	2018-07-05
Pharmaceutically acceptable solubilizing composition and pharmaceutical dosage form containing same Grant 9,616,130 - Rosenberg , et al. April 11, 2	2017-04-11
Test solvent for evaluating the compatibility of biologically active substances and graft copolymers Grant 9,594,073 - Breitenbach , et al. March 14, 2	2017-03-14
Process for producing a solid dispersion of an active ingredient Grant 9,414,992 - Kessler , et al. August 16, 2	2016-08-16
Pharmaceutical dosage form comprising polymeric carrier composition Grant 9,402,909 - Liepold , et al. August 2, 2	2016-08-02
Process for producing a solid dispersion of an active ingredient Grant 9,205,027 - Kessler , et al. December 8, 2	2015-12-08
Pharmaceutically Acceptable Solubilizing Composition and Pharmaceutical Dosage Form Containing Same App 20150314000 - Rosenberg; Jorg ; et al.	2015-11-05
Pharmaceutically acceptable solubilizing composition and pharmaceutical dosage form containing same Grant 9,078,921 - Rosenberg , et al. July 14, 2	2015-07-14
Delivery system for sustained release of a calcium-channel blocking agent Grant 9,060,986 - Breitenbach , et al. June 23, 2	2015-06-23
Rate-controlled particles Grant 9,028,876 - Hantke , et al. May 12, 2	2015-05-12
Melt-processed imatinib dosage form Grant 8,841,303 - Breitenbach , et al. September 23, 2	2014-09-23
Pharmaceutical Dosage Form Comprising Polymeric Carrier Composition App 20140200278 - Liepold; Bernd ; et al.	2014-07-17
Process For Producing A Solid Dispersion Of An Active Ingredient App 20140094479 - Kessler; Thomas ; et al.	2014-04-03
Process For Producing A Solid Dispersion Of An Active Ingredient App 20140087060 - Kessler; Thomas ; et al.	2014-03-27
Solid dosage form with a film containing an active substance, as well as its method of production Grant 8,673,344 - Rosenberg , et al. March 18, 2	2014-03-18
Curcuminoid Solid Dispersion Formulation App 20130303628 - Breitenbach; Jorg ; et al.	2013-11-14
Self-emulsifying active substance formulation and use of this formulation Grant 8,470,347 - Berndl , et al. June 25, 2	2013-06-25
Test Solvent For Evaluating The Compatibility Of Biologically Active Substances And Graft Copolymers App 20130118238 - Breitenbach; Jorg ; et al.	2013-05-16
Solid pharmaceutical dosage formulation Grant 8,377,952 - Rosenberg , et al. February 19, 2	2013-02-19
Solid Pharmaceutical Dosage Formulation App 20130004578 - Rosenberg; Jorg ; et al.	2013-01-03
Delivery System For Sustained Release Of A Calcium-channel Blocking Agent App 20120252851 - Breitenbach; Jorg ; et al.	2012-10-04
Self-Emulsifying Active Ingredient Formulation and the Use of this Formulation App 20120225953 - Berndl; Gunther ; et al.	2012-09-06
Solid Pharmaceutical Dosage Form App 20120202858 - Rosenberg; Joerg ; et al.	2012-08-09
Rate-controlled Particles App 20120172364 - Hantke; Thomas ; et al.	2012-07-05
Formulation Comprising Fenofibric Acid, A Physiologically Acceptable Salt Or Derivative Thereof App 20120046360 - Rosenberg; Joerg ; et al.	2012-02-23
Solid Pharmaceutical Dosage Form App 20120022089 - Rosenberg; Joerg ; et al.	2012-01-26
Pharmaceutical Dosage Form Comprising Polymeric Carrier Composition App 20110182891 - Liepold; Bernd ; et al.	2011-07-28
Self-emulsifying Active Substance Formulation And Use Of This Formulation App 20110123652 - Berndl; Gunther ; et al.	2011-05-26
Solubilizing aids in powder form for solid pharmaceutical presentation forms Grant 7,906,144 - Berndl , et al. March 15, 2	2011-03-15
Solid Pharmaceutical Dosage Form App 20110008430 - Rosenberg; Jorg ; et al.	2011-01-13
Pharmaceutical Dosage Form Comprising A Liquid Or Flowable Core Composition App 20100297223 - Rosenberg; Jorg ; et al.	2010-11-25
Pharmaceutically Acceptable Solubilizing Composition And Pharmaceutical Dosage Form Containing Same App 20100247635 - Rosenberg; Jorg ; et al.	2010-09-30
Melt-processed Imatinib Dosage Form App 20100240672 - Breitenbach; Jorg ; et al.	2010-09-23
Solid Dosage Form With A Film Containing An Active Substance, As Well As Its Method Of Production App 20100119583 - Rosenberg; Jorg ; et al.	2010-05-13
Nanoparticulate core shell systems and the use thereof in pharmaceutical and cosmetic preparation Grant 7,687,071 - Heger , et al. March 30, 2	2010-03-30
Process For Producing A Solid Dispersion Of An Active Ingredient App 20090311414 - Kessler; Thomas ; et al.	2009-12-17
Process For Producing A Solid Dispersion Of An Active Ingredient App 20090302493 - Kessler; Thomas ; et al.	2009-12-10
Production Of Enveloped Pharmaceutical Dosage Forms App 20090274731 - Rosenberg; Jorg ; et al.	2009-11-05
Composition and Dosage Form Comprising a Solid or Semi-Solid Matrix App 20090220596 - Rosenberg; Jorg ; et al.	2009-09-03
Production of Dosing Molds from Active Substance-Containing Melts App 20090050262 - Rosenberg; Jorg ; et al.	2009-02-26
Production of Dosage Forms Comprising a Solid Dispersion of a Microcrystalline Agent App 20090012184 - Rosenberg; Jorg ; et al.	2009-01-08
Solid Pharmaceutical Dosage Formulation App 20080299203 - Rosenberg; Joerg ; et al.	2008-12-04
Formulation based on heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base Grant 7,393,840 - Rosenberg , et al. July 1, 2	2008-07-01
Formulation Obtained From A Powder Mixture Comprising An Inorganic Pigment App 20080107733 - Fastnacht; Katja ; et al.	2008-05-08
Solid Pharmaceutical Dosage Form App 20070249643 - Rosenberg; Joerg ; et al.	2007-10-25
Dosage forms for the delivery of drugs of abuse and related methods App 20070190142 - BREITENBACH; Jorg ; et al.	2007-08-16
Method for producing water dispersible dry powders from poorly soluble compounds App 20060269610 - Rosenberg; Jorg ; et al.	2006-11-30
Method of producing solid shape forms containing an active ingredient Grant 7,014,810 - Krull , et al. March 21, 2	2006-03-21
Solid pharmaceutical dosage formulation App 20050143404 - Rosenberg, Joerg ; et al.	2005-06-30
Solid pharmaceutical dosage form App 20050084529 - Rosenberg, Joerg ; et al.	2005-04-21
Solid pharmaceutical dosage form App 20050048112 - Breitenbach, Jorg ; et al.	2005-03-03
Multiphase active ingredient-containing formulations Grant 6,787,157 - Rosenberg , et al. September 7, 2	2004-09-07
Process for producing solid creatine dosage forms and dosage forms obtainable thereby Grant 6,689,299 - Kessel , et al. February 10, 2	2004-02-10
Self-emulsifying active substance formulation and use of this formulation App 20040013697 - Berndl, Gunther ; et al.	2004-01-22
Depth-type filter for killing microorganisms and inactivating viruses and its use Grant 6,627,088 - Breitenbach , et al. September 30, 2	2003-09-30
Formulation based on heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base App 20030161884 - Rosenberg, Jorg ; et al.	2003-08-28
Torasemide-containing pharmaceutical preparations App 20030153608 - Maegerlein, Markus ; et al.	2003-08-14
Test system for characterizing the compatibility of bioactive substances and polyvinylpyrrolidone Grant 6,599,931 - Breitenbach , et al. July 29, 2	2003-07-29
Mechanically stable pharmaceutical presentations form containing liquid or semisolid surface-active substances Grant 6,599,528 - Rosenberg , et al. July 29, 2	2003-07-29
Method for producing solvent-free noncrystalline biologically active substances Grant 6,547,997 - Breitenbach , et al. April 15, 2	2003-04-15
Device and method for producing solid shape containing an active ingredient App 20030015814 - Krull, Harald ; et al.	2003-01-23
Formulation based on lipoic acid, process for its production and the use of this formulation for oral administration of lipoic acid App 20020151578 - Breitenbach, Jorg ; et al.	2002-10-17
Process for producing solid dosage forms Grant 6,423,256 - Kothrade , et al. July 23, 2	2002-07-23
Use of lipids as adjuvents in the production of solid medicinal forms by the melt extrusion process Grant 6,387,401 - Rosenberg , et al. May 14, 2	2002-05-14
Process for producing solid creatine dosage forms and dosage forms obtainable thereby App 20010042936 - Kessel, Knut ; et al.	2001-11-22
Method for producing small-particle preparations of biologically active substances Grant 6,318,650 - Breitenbach , et al. November 20, 2	2001-11-20
Polymer powders redispersible in aqueous solution Grant 6,281,282 - Breitenbach , et al. August 28, 2	2001-08-28
Use Of Lipids As Adjuvents In The Production Of Solid Medicinal Forms By The Melt Extrusion Process App 20010007664 - ROSENBERG, JOERG ; et al.	2001-07-12
Topical Products as prophylactic of curative agents for bacterial skin infections Grant 6,231,848 - Breitenbach , et al. May 15, 2	2001-05-15
Process for producing solid dosage forms by extrusion Grant 6,221,368 - Breitenbach , et al. April 24, 2	2001-04-24
Solid medicaments obtained by extrusion of an isomalt-containing polymer-active substance melt Grant 6,187,342 - Zeidler , et al. February 13, 2	2001-02-13
Solid foamed active substance preparations Grant 6,150,424 - Breitenbach , et al. November 21, 2	2000-11-21
Production of lenticular tablets by melt calendering Grant 6,132,659 - Rosenberg , et al. October 17, 2	2000-10-17
Method of producing multi-layer medicaments in solid form for oral or rectal administration Grant 6,120,802 - Breitenbach , et al. September 19, 2	2000-09-19
Transparent rapid release compositions of non-steroidal analgesics Grant 6,063,821 - Breitenbach , et al. May 16, 2	2000-05-16
Production of solid drug forms Grant 6,051,253 - Zettler , et al. April 18, 2	2000-04-18
Process and apparatus for the production of divisible tablets Grant 6,009,690 - Rosenberg , et al. January 4, 2	2000-01-04
Process for producing solid drug forms having at least two phases Grant 6,001,391 - Zeidler , et al. December 14, 1	1999-12-14
Preparation of salts of pharmaceutical active substances which have acidic groups Grant 5,969,181 - Breitenbach , et al. October 19, 1	1999-10-19
Polymer/hydrogen peroxide complexes Grant 5,945,032 - Breitenbach , et al. August 31, 1	1999-08-31
Solid active extrusion compound preparations containing low-substituted hydroxypropylcellulose Grant 5,939,099 - Grabowski , et al. August 17, 1	1999-08-17
Production of covered tablets Grant 5,897,910 - Rosenberg , et al. April 27, 1	1999-04-27
Pyrrolidonyl-containing polyesters and polyamides Grant 5,880,252 - Kim , et al. March 9, 1	1999-03-09
Preparation of polymers comprising peroxycarboxyl groups Grant 5,804,669 - Tropsch , et al. September 8, 1	1998-09-08
The production of active substance compositions in the form of a solid solution of the active substance in a polymer matrix, and active substance compositions produced by this process Grant 5,741,519 - Rosenberg , et al. April 21, 1	1998-04-21
Preparation of hydrogen peroxide/polymer complexes in powder form Grant 5,674,436 - Breitenbach , et al. October 7, 1	1997-10-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.